463 related articles for article (PubMed ID: 27981615)
1. Metabolic and histological implications of intrahepatic triglyceride content in nonalcoholic fatty liver disease.
Bril F; Barb D; Portillo-Sanchez P; Biernacki D; Lomonaco R; Suman A; Weber MH; Budd JT; Lupi ME; Cusi K
Hepatology; 2017 Apr; 65(4):1132-1144. PubMed ID: 27981615
[TBL] [Abstract][Full Text] [Related]
2. Nonalcoholic fatty liver disease is associated with hepatic and skeletal muscle insulin resistance in overweight adolescents.
Deivanayagam S; Mohammed BS; Vitola BE; Naguib GH; Keshen TH; Kirk EP; Klein S
Am J Clin Nutr; 2008 Aug; 88(2):257-62. PubMed ID: 18689359
[TBL] [Abstract][Full Text] [Related]
3. Liver, muscle, and adipose tissue insulin action is directly related to intrahepatic triglyceride content in obese subjects.
Korenblat KM; Fabbrini E; Mohammed BS; Klein S
Gastroenterology; 2008 May; 134(5):1369-75. PubMed ID: 18355813
[TBL] [Abstract][Full Text] [Related]
4. Change in hepatic fat content measured by MRI does not predict treatment-induced histological improvement of steatohepatitis.
Bril F; Barb D; Lomonaco R; Lai J; Cusi K
J Hepatol; 2020 Mar; 72(3):401-410. PubMed ID: 31589891
[TBL] [Abstract][Full Text] [Related]
5. Effect of adipose tissue insulin resistance on metabolic parameters and liver histology in obese patients with nonalcoholic fatty liver disease.
Lomonaco R; Ortiz-Lopez C; Orsak B; Webb A; Hardies J; Darland C; Finch J; Gastaldelli A; Harrison S; Tio F; Cusi K
Hepatology; 2012 May; 55(5):1389-97. PubMed ID: 22183689
[TBL] [Abstract][Full Text] [Related]
6. The role of liver fat and insulin resistance as determinants of plasma aminotransferase elevation in nonalcoholic fatty liver disease.
Maximos M; Bril F; Portillo Sanchez P; Lomonaco R; Orsak B; Biernacki D; Suman A; Weber M; Cusi K
Hepatology; 2015 Jan; 61(1):153-60. PubMed ID: 25145475
[TBL] [Abstract][Full Text] [Related]
7. High Prevalence of Nonalcoholic Fatty Liver Disease in Patients With Type 2 Diabetes Mellitus and Normal Plasma Aminotransferase Levels.
Portillo-Sanchez P; Bril F; Maximos M; Lomonaco R; Biernacki D; Orsak B; Subbarayan S; Webb A; Hecht J; Cusi K
J Clin Endocrinol Metab; 2015 Jun; 100(6):2231-8. PubMed ID: 25885947
[TBL] [Abstract][Full Text] [Related]
8. Plasma thyroid hormone concentration is associated with hepatic triglyceride content in patients with type 2 diabetes.
Bril F; Kadiyala S; Portillo Sanchez P; Sunny NE; Biernacki D; Maximos M; Kalavalapalli S; Lomonaco R; Suman A; Cusi K
J Investig Med; 2016 Jan; 64(1):63-8. PubMed ID: 26755815
[TBL] [Abstract][Full Text] [Related]
9. Effect of fenofibrate and niacin on intrahepatic triglyceride content, very low-density lipoprotein kinetics, and insulin action in obese subjects with nonalcoholic fatty liver disease.
Fabbrini E; Mohammed BS; Korenblat KM; Magkos F; McCrea J; Patterson BW; Klein S
J Clin Endocrinol Metab; 2010 Jun; 95(6):2727-35. PubMed ID: 20371660
[TBL] [Abstract][Full Text] [Related]
10. Hepatic Steatosis and Insulin Resistance, But Not Steatohepatitis, Promote Atherogenic Dyslipidemia in NAFLD.
Bril F; Sninsky JJ; Baca AM; Superko HR; Portillo Sanchez P; Biernacki D; Maximos M; Lomonaco R; Orsak B; Suman A; Weber MH; McPhaul MJ; Cusi K
J Clin Endocrinol Metab; 2016 Feb; 101(2):644-52. PubMed ID: 26672634
[TBL] [Abstract][Full Text] [Related]
11. Metabolic Impact of Nonalcoholic Steatohepatitis in Obese Patients With Type 2 Diabetes.
Lomonaco R; Bril F; Portillo-Sanchez P; Ortiz-Lopez C; Orsak B; Biernacki D; Lo M; Suman A; Weber MH; Cusi K
Diabetes Care; 2016 Apr; 39(4):632-8. PubMed ID: 26861926
[TBL] [Abstract][Full Text] [Related]
12. Insulin resistance drives hepatic de novo lipogenesis in nonalcoholic fatty liver disease.
Smith GI; Shankaran M; Yoshino M; Schweitzer GG; Chondronikola M; Beals JW; Okunade AL; Patterson BW; Nyangau E; Field T; Sirlin CB; Talukdar S; Hellerstein MK; Klein S
J Clin Invest; 2020 Mar; 130(3):1453-1460. PubMed ID: 31805015
[TBL] [Abstract][Full Text] [Related]
13. Plasma Fibroblast Growth Factor 21 Is Associated With Severity of Nonalcoholic Steatohepatitis in Patients With Obesity and Type 2 Diabetes.
Barb D; Bril F; Kalavalapalli S; Cusi K
J Clin Endocrinol Metab; 2019 Aug; 104(8):3327-3336. PubMed ID: 30848827
[TBL] [Abstract][Full Text] [Related]
14. Nonalcoholic fatty liver disease: a feature of the metabolic syndrome.
Marchesini G; Brizi M; Bianchi G; Tomassetti S; Bugianesi E; Lenzi M; McCullough AJ; Natale S; Forlani G; Melchionda N
Diabetes; 2001 Aug; 50(8):1844-50. PubMed ID: 11473047
[TBL] [Abstract][Full Text] [Related]
15. Effect of a ketogenic diet on hepatic steatosis and hepatic mitochondrial metabolism in nonalcoholic fatty liver disease.
Luukkonen PK; Dufour S; Lyu K; Zhang XM; Hakkarainen A; Lehtimäki TE; Cline GW; Petersen KF; Shulman GI; Yki-Järvinen H
Proc Natl Acad Sci U S A; 2020 Mar; 117(13):7347-7354. PubMed ID: 32179679
[TBL] [Abstract][Full Text] [Related]
16. Effect of canagliflozin treatment on hepatic triglyceride content and glucose metabolism in patients with type 2 diabetes.
Cusi K; Bril F; Barb D; Polidori D; Sha S; Ghosh A; Farrell K; Sunny NE; Kalavalapalli S; Pettus J; Ciaraldi TP; Mudaliar S; Henry RR
Diabetes Obes Metab; 2019 Apr; 21(4):812-821. PubMed ID: 30447037
[TBL] [Abstract][Full Text] [Related]
17. Dissociation between intrahepatic triglyceride content and insulin resistance in familial hypobetalipoproteinemia.
Amaro A; Fabbrini E; Kars M; Yue P; Schechtman K; Schonfeld G; Klein S
Gastroenterology; 2010 Jul; 139(1):149-53. PubMed ID: 20303351
[TBL] [Abstract][Full Text] [Related]
18. Visceral adipose tissue tracks more closely with metabolic dysfunction than intrahepatic triglyceride in lean Asians without diabetes.
Ding C; Chan Z; Chooi YC; Choo J; Sadananthan SA; Michael N; Velan SS; Leow MKS; Magkos F
J Appl Physiol (1985); 2018 Sep; 125(3):909-915. PubMed ID: 29745794
[TBL] [Abstract][Full Text] [Related]
19. Influence of adiposity, insulin resistance, and intrahepatic triglyceride content on insulin kinetics.
Smith GI; Polidori DC; Yoshino M; Kearney ML; Patterson BW; Mittendorfer B; Klein S
J Clin Invest; 2020 Jun; 130(6):3305-3314. PubMed ID: 32191646
[TBL] [Abstract][Full Text] [Related]
20. Alterations in fatty acid kinetics in obese adolescents with increased intrahepatic triglyceride content.
Fabbrini E; deHaseth D; Deivanayagam S; Mohammed BS; Vitola BE; Klein S
Obesity (Silver Spring); 2009 Jan; 17(1):25-9. PubMed ID: 18948971
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
